Bajaj Healthcare Ltd.

290.55

-2.9 (-1%)stock indicator image for downward trend

BAJAJHCARE Share Price
As on June 8, 2026
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap973 Cr
P/E Ratio21.38
Dividend Yield0.07 %
Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

This image for unlock stock of the monthUnlock Stock of the Month

T&C*

Company Information


Market Insights
Open292.7
High295.35
NSE SymbolBAJAJHCARE
Close290.55
Low289
BSE Symbol539872
Previous Years High/Low
1 Year High552.6
3 Year High745
5 Year High745
1 Year Low272.35
3 Year Low263.3
5 Year Low257.45

Technicals


IndicatorsValueSignal
5-DMA295.42Bearish
10-DMA298.81Bearish
20-DMA296.53Bearish
50-DMA314Bearish
100-DMA330.21Bearish
200-DMA385.23Bearish

Historical Performance


1 Year
-44.8%
3 Years
-0.5%
5 Years
N/A
10 Years
N/A

Shareholding Pattern


%

Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


Compounded Sales Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Compounded Profit Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Stock Price CAGR
10 Years:N/A
5 Years:N/A
3 Years:0.6
TTM:-45.4
Return on Equity
10 Years:N/A
5 Years:N/A
3 Years:N/A
last year:N/A

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a moderate PE of 21.38, suggesting fair valuation relative to earnings.
  • Over the last three years, the stock delivered a weak 3-year price CAGR of 0.6%, indicating poor shareholder returns.
  • The stock carries a beta of 1.2, indicating volatility broadly in line with the market.
  • In the last financial year, the company reported an EBITDA of ₹1020 million, reflecting positive operating performance.
  • In the previous financial year, the company generated revenue of ₹5426 million, suggesting a mid-sized operation.

Investment Calculator


Investment Amount: ₹ 1000000
Current Value: ₹ 546557.6
No. of Shares: 1881 (Approx)
Performance:-45.3%
P/L: ₹-453442.4
NIFTY Performance: -7.9%
1 day Top Gainers
SymbolChange%
CCL1173(9%)
INOXINDIA1665.1(6%)
RELINFRA85.84(5%)
CAPLIPOINT2111(4%)
BALRAMCHIN550.4(4%)
1 Day Top Losers
SymbolChange%
NETWEB4264.5(-9%)
WIPRO181.76(-8%)
GMDCLTD609.65(-7%)
IFCI73.8(-7%)
GVT&D4744(-6%)
MUTHOOTFIN2964.7(-6%)
FSL252(-6%)
TTML43.48(-6%)

Top Performing Stocks from the same sector


Venus Remedies Ltd.

68.4%

1695.4

1 Month Performance

Bliss GVS Pharma Ltd.

55.6%

419.6

1 Month Performance

Bafna Pharmaceuticals Ltd.

46.9%

193.97

1 Month Performance

Panacea Biotec Ltd.

42.2%

552.9

1 Month Performance

Sakar Healthcare Ltd.

40.7%

767.6

1 Month Performance

Brooks Laboratories Ltd.

33.5%

66.66

1 Month Performance

Ortin Global Ltd.

32.9%

19.92

1 Month Performance

IOL Chemicals And Pharmaceuticals Ltd.

31%

126.92

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month